The fight to get Vertex’s cystic fibrosis drug Orkambi available on England’s NHS continues, after pressure groups called on the government to implement a little-known law allowing to set aside ...
Analysts expect the Boston, Massachusetts-based company to report quarterly earnings at $4.58 per share, up from $4.38 per share in the year-ago period. The consensus estimate for Vertex ...
'It's not going to be easy, but I really hope Virat comes out of this.' IMAGE: Virat Kohli has perished for ducks in the first two ODIs against Australia. Photograph: BCCI Spin great Ravichandran ...
TipRanks on MSN
Vertex price target lowered to $28 from $35 at Jefferies
Jefferies analyst Samad Samana lowered the firm’s price target on Vertex (VERX) to $28 from $35 and keeps a Buy rating on the shares. Final ...
While the launches of Journavx and Casgevy have started to build steam, “investors may not be inclined to look past the clear ...
Hosted on MSN
Low-pressure area to form over southeast Bay of Bengal, Odisha to get rainfall: IMD warns
Bhubaneswar (Odisha), Oct 20, 2025 (ANI): Giving weather update, IMD Bhubaneswar Director Manorama Mohanty on Oct 20 informed that low-pressure area is likely to form over the southeast Bay of Bengal ...
NHS England has signed an agreement with US pharma Vertex covering all the company’s licensed cystic fibrosis medicines, and any future uses for them. The deal follows a three-year stand off between ...
This was the first time in his career that Virat Kohli was dismissed for a duck in consecutive ODI innings. Despite Virat Kohli’s illustrious ODI career, his most cherished format, where he holds the ...
Click to deselect and select. Oct 10, 2025, 10:57 PM IST Vertex Securitie - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Sep 19, 2025, 9:41 PM IST Vertex Securitie - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback